Press Release
BusinessHealthcare

Celiac Disease Market Insight, Epidemiology and Market Forecast 2028

It highlights the existing treatment patterns, potential upcoming drugs and also identifies best of the market opportunities by providing the current and forecasted market revenue, sales trends, and drug uptake during the study period from 2016-2028.

DelveInsight’s Celiac Disease Market Insights, Epidemiology and Market Forecast 2028” report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology. It highlights the existing treatment patterns, potential upcoming drugs and also identifies best of the market opportunities by providing the current and forecasted market revenue, sales trends, and drug uptake during the study period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain and the United Kingdom)
• Japan

Study Period: 2016-2028

Celiac Disease (CD) Understanding and Treatment Algorithm
The report provides the in depth analysis of the disease overview by providing details such as disease definition, classification, symptoms, etiology, pathophysiology and diagnostic trends. The comprehensive details about treatment algorithms and treatment guidelines for Celiac Disease (CD) in the US, Europe, and Japan are also provided in the report.

Celiac Disease (CD) Epidemiology
This section provide the insights about historical and current patient pool and forecasted trend for 7 major markets. It takes in to account the analysis of numerous studies, survey reports as well as KOL’s views which helps to recognize the factors behind the current and forecasted trends, diagnosed and treatable patient pool along with assumptions undertaken.

Celiac Disease (CD) Product Profiles & Analysis
This part of the Celiac Disease (CD) report encloses the detailed analysis of marketed drugs and Phase III and late Phase II pipeline drugs. It provides the key cross competition which evaluates the drugs on several parameters including, safety & efficacy results, mechanism of action, route, launch dates and designations. This section also covers the market intelligence and tracking of latest happenings, agreements and collaborations, approvals, patent details and other major breakthroughs.

Celiac Disease (CD) Market Outlook
The Celiac Disease (CD) market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology. This segment analyses the market trend of each marketed drug and late-stage pipeline drugs. This is done by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders . The calculated market data is presented with relevant tables and graphs to give a clear view of the market at first sight.

Celiac Disease (CD) Market Share by Therapies
This section focusses on the rate of uptake of the potential drugs recently launched or will be launched in the market during the study period from 2016-2028. The analysis covers market uptake by drugs; patient uptake by therapies and sales of each drug. This information also helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It provides the comparison of the drugs on the basis of market share and size. This analysis helps in investigating factors important in market uptake and in making financial as well as regulatory decisions.

Celiac Disease (CD) Report Insights
• Patient Population in Celiac Disease (CD)
• Therapeutic Approaches in Celiac Disease (CD)
• Celiac Disease (CD) Pipeline Analysis
• Celiac Disease (CD) Market Size and Trends
• Celiac Disease (CD) Market Opportunities
• Impact of upcoming Therapies in Celiac Disease (CD)

Request for sample pages

Celiac Disease (CD) Report Key Strengths
• 10 Year Forecast
• 7MM Coverage
• Epidemiology Segmentation
• Drugs Uptake
• Highly Analyzed Market
• Key Cross Competition

Celiac Disease (CD) Report Assessment
• Current Treatment Practices in Celiac Disease (CD)
• Unmet Needs in Celiac Disease (CD)
• Detailed Celiac Disease (CD) Pipeline Product Profiles
• Market Attractiveness
• Market Drivers and Barriers

Key Benefits
• This DelveInsight report will help to develop Business Strategies by understanding the trends shaping and driving the Celiac Disease (CD) market
• Organize sales and marketing efforts by identifying the best opportunities for Celiac Disease (CD) market
• To understand the future market competition in the Celiac Disease (CD) market.

Table of contents

1. Report Introduction
2. Celiac Disease (CD) Market Overview at a Glance
2.1. Market Share Distribution of Celiac Disease (CD) in 2017
2.2. Market Share Distribution of Celiac Disease (CD) in 2028
3. Disease Background and Overview: Celiac Disease (CD)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Celiac Disease (CD) in 7MM
4.3. Total Prevalent Patient Population of Celiac Disease (CD) in 7MM – By Countries
5. Epidemiology of Celiac Disease (CD) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Celiac Disease (CD)
5.1.3. Sub-Type Specific cases of the Celiac Disease (CD)
5.1.4. Sex- Specific Cases of the Celiac Disease (CD)
5.1.5. Diagnosed Cases of the Celiac Disease (CD)
5.1.6. Treatable Cases of the Celiac Disease (CD)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Celiac Disease (CD)
5.4.3. Sub-Type Specific cases of the Celiac Disease (CD)
5.4.4. Sex- Specific Cases of the Celiac Disease (CD)
5.4.5. Diagnosed Cases of the Celiac Disease (CD)
5.4.6. Treatable Cases of the Celiac Disease (CD)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Celiac Disease (CD)
5.5.3. Sub-Type Specific cases of the Celiac Disease (CD)
5.5.4. Sex- Specific Cases of the Celiac Disease (CD)
5.5.5. Diagnosed Cases of the Celiac Disease (CD)
5.5.6. Treatable Cases of the Celiac Disease (CD)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Celiac Disease (CD)
5.6.3. Sub-Type Specific cases of the Celiac Disease (CD)
5.6.4. Sex- Specific Cases of the Celiac Disease (CD)
5.6.5. Diagnosed Cases of the Celiac Disease (CD)
5.6.6. Treatable Cases of the Celiac Disease (CD)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Celiac Disease (CD)
5.7.3. Sub-Type Specific cases of the Celiac Disease (CD)
5.7.4. Sex- Specific Cases of the Celiac Disease (CD)
5.7.5. Diagnosed Cases of the Celiac Disease (CD)
5.7.6. Treatable Cases of the Celiac Disease (CD)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Celiac Disease (CD)
5.8.3. Sub-Type Specific cases of the Celiac Disease (CD)
5.8.4. Sex- Specific Cases of the Celiac Disease (CD)
5.8.5. Diagnosed Cases of the Celiac Disease (CD)
5.8.6. Treatable Cases of the Celiac Disease (CD)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Celiac Disease (CD)
5.9.3. Sub-Type Specific cases of the Celiac Disease (CD)
5.9.4. Sex- Specific Cases of the Celiac Disease (CD)
5.9.5. Diagnosed Cases of the Celiac Disease (CD)
5.9.6. Treatable Cases of the Celiac Disease (CD)
6. Current Treatment & Medical practices
6.1. Treatment Algorithm
6.2. Treatment Guidelines
7. Unmet Needs of the Celiac Disease (CD)
8. Marketed Therapies
8.1. Drug A: Company 1
8.1.1. Drug Description
8.1.2. Mechanism of Action
8.1.3. Regulatory Milestones
8.1.4. Advantages & Disadvantages
8.1.5. Product Profile
8.2. Drug B: Company 2
8.2.1. Drug Description
8.2.2. Mechanism of Action
8.2.3. Regulatory Milestones
8.2.4. Advantages & Disadvantages
8.2.5. Product Profile
9. Pipeline Therapies – At a glance
10. Key Cross Competition
11. Emerging Therapies for Celiac Disease (CD)
11.1. Drug C: Company 3
11.1.1. Drug Description
11.1.2. Clinical Trials Details
11.1.3. Safety and Efficacy Profile
11.1.4. Advantages & Disadvantages
11.1.5. Pipeline Development Activities
11.1.6. Product Profile
11.2. Drug D: Company 4
11.2.1. Drug Description
11.2.2. Clinical Trials Details
11.2.3. Safety and Efficacy Profile
11.2.4. Advantages & Disadvantages
11.2.5. Pipeline Development Activities
11.2.6. Product Profile
12. Celiac Disease (CD): 7MM Market Analysis
12.1. 7MM Market Size of Celiac Disease (CD)
12.2. 7MM Percentage Share of drugs marketed for Celiac Disease (CD)
12.3. 7MM Market Sales of Celiac Disease (CD) by Products
13. Celiac Disease (CD): Country-Wise Market Analysis
13.1. United States
13.1.1. Market Size of Celiac Disease (CD) in United States
13.1.2. Percentage Share of drugs marketed for Celiac Disease (CD) in United States
13.1.3. Market Sales of Celiac Disease (CD) by Products in United States
13.1.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2. EU-5
13.2.1. Germany
13.2.1.1. Market Size of Celiac Disease (CD) in Germany
13.2.1.2. Percentage Share of drugs marketed for Celiac Disease (CD) in Germany
13.2.1.3. Market Sales of Celiac Disease (CD) by Products in Germany
13.2.1.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.2. France
13.2.2.1. Market Size of Celiac Disease (CD) in France
13.2.2.2. Percentage Share of drugs marketed for Celiac Disease (CD) in France
13.2.2.3. Market Sales of Celiac Disease (CD) by Products in France
13.2.2.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.3. Italy
13.2.3.1. Market Size of Celiac Disease (CD) in Italy
13.2.3.2. Percentage Share of drugs marketed for Celiac Disease (CD) in Italy
13.2.3.3. Market Sales of Celiac Disease (CD) by Products in Italy
13.2.3.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.4. Spain
13.2.4.1. Market Size of Celiac Disease (CD) in Spain
13.2.4.2. Percentage Share of drugs marketed for Celiac Disease (CD) in Spain
13.2.4.3. Market Sales of Celiac Disease (CD) by Products in Spain
13.2.4.4. Analysis of Upcoming Therapies and their Impact on the Market
13.2.5. United Kingdom
13.2.5.1. Market Size of Celiac Disease (CD) in United Kingdom
13.2.5.2. Percentage Share of drugs marketed for Celiac Disease (CD) in United Kingdom
13.2.5.3. Market Sales of Celiac Disease (CD) by Products in United Kingdom
13.2.5.4. Analysis of Upcoming Therapies and their Impact on the Market
13.3. Japan
13.3.1. Market Size of Celiac Disease (CD) in Japan
13.3.2. Percentage Share of drugs marketed for Celiac Disease (CD) in Japan
13.3.3. Market Sales of Celiac Disease (CD) by Products in Japan
13.3.4. Analysis of Upcoming Therapies and their Impact on the Market
14. Market Drivers
15. Market Barriers
16. Appendix
17. Report Methodology
17.1. Sources
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight

Tags
Close